{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T01:21:48Z","timestamp":1794014508190,"version":"4.8.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jmdjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Molecular Diagnostics"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.jmoldx.2026.01.002","type":"journal-article","created":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T16:25:37Z","timestamp":1768926337000},"page":"377-388","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Technical Validation and Prospective Clinical Utility of Optical Genome Mapping in Acute Leukemia Workup"],"prefix":"10.1016","volume":"28","author":[{"given":"Julia N.C.","family":"Parlow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeid","family":"Hamadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Salcedo-Porras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatma","family":"AlBulushi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3360-5471","authenticated-orcid":false,"given":"Eric","family":"McGinnis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-8523-5166","authenticated-orcid":false,"given":"Tara","family":"Spence","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmoldx.2026.01.002_bib1","doi-asserted-by":"crossref","first-page":"250","DOI":"10.3747\/co.v18i5.775","article-title":"Canadian College of Medical Geneticists guidelines for the indications, analysis, and reporting of cancer specimens","volume":"18","author":"Dawson","year":"2011","journal-title":"Curr Oncol"},{"key":"10.1016\/j.jmoldx.2026.01.002_bib2","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1002\/ajh.26587","article-title":"Optical genome mapping for structural variation analysis in hematologic malignancies","volume":"97","author":"Smith","year":"2022","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jmoldx.2026.01.002_bib3","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3390\/diagnostics14020165","article-title":"Optical genome mapping for chromosomal aberrations detection \u2013 false-negative results and contributing factors","volume":"14","author":"Xu","year":"2024","journal-title":"Diagnostics"},{"key":"10.1016\/j.jmoldx.2026.01.002_bib4","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3390\/jpm14030291","article-title":"Integrating optical genome mapping and whole genome sequencing in somatic structural variant detection","volume":"14","author":"Budurlean","year":"2024","journal-title":"J Pers Med"},{"key":"10.1016\/j.jmoldx.2026.01.002_bib5","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.3390\/cancers17213445","article-title":"The silent revolution of the genome: the role of optical genome mapping in acute lymphoblastic leukemia","volume":"17","author":"Simio","year":"2025","journal-title":"Cancers"},{"key":"10.1016\/j.jmoldx.2026.01.002_bib6","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/s41408-022-00718-1","article-title":"Optical genome mapping refines cytogenetic diagnostics, prognostic stratification and provides new molecular insights in adult MDS\/AML patients","volume":"12","author":"Balducci","year":"2022","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.jmoldx.2026.01.002_bib7","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1002\/ijc.33942","article-title":"Optical genome mapping reveals additional prognostic information compared to conventional cytogenetics in AML\/MDS patients","volume":"150","author":"Gerding","year":"2022","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jmoldx.2026.01.002_bib8","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/gcc.22971","article-title":"Optical genome mapping, a promising alternative to gold standard cytogenetic approaches in a series of acute lymphoblastic leukemias","volume":"60","author":"Lestringant","year":"2021","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.jmoldx.2026.01.002_bib9","doi-asserted-by":"crossref","first-page":"4388","DOI":"10.3390\/cancers13174388","article-title":"The clinical utility of optical genome mapping for the assessment of genomic aberrations in acute lymphoblastic leukemia","volume":"13","author":"L\u00fchmann","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jmoldx.2026.01.002_bib10","doi-asserted-by":"crossref","first-page":"3376","DOI":"10.3390\/cancers14143376","article-title":"Optical genome mapping: a promising new tool to assess genomic complexity in chronic lymphocytic leukemia (CLL)","volume":"14","author":"Puiggros","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jmoldx.2026.01.002_bib11","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/ajh.26487","article-title":"Optimizing the diagnostic workflow for acute lymphoblastic leukemia by optical genome mapping","volume":"97","author":"Rack","year":"2022","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jmoldx.2026.01.002_bib12","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1038\/s41375-022-01652-8","article-title":"High-resolution structural variant profiling of myelodysplastic syndromes by optical genome mapping uncovers cryptic aberrations of prognostic and therapeutic significance","volume":"36","author":"Yang","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.jmoldx.2026.01.002_bib13","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1182\/bloodadvances.2022007583","article-title":"Optical genome mapping in acute myeloid leukemia: a multicenter evaluation","volume":"7","author":"Levy","year":"2023","journal-title":"Blood Adv"},{"key":"10.1016\/j.jmoldx.2026.01.002_bib14","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1002\/ajh.27435","article-title":"Optical genome mapping improves the accuracy of classification, risk stratification, and personalized treatment strategies for patients with acute myeloid leukemia","volume":"99","author":"Loghavi","year":"2024","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jmoldx.2026.01.002_bib15","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/j.ajhg.2021.06.001","article-title":"Next-generation cytogenetics: comprehensive assessment of 52 hematological malignancy genomes by optical genome mapping","volume":"108","author":"Neveling","year":"2021","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jmoldx.2026.01.002_bib16","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.jmoldx.2022.09.009","article-title":"Clinical validation and diagnostic utility of optical genome mapping for enhanced cytogenomic analysis of hematological neoplasms","volume":"24","author":"Sahajpal","year":"2022","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.jmoldx.2026.01.002_bib17","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.3390\/cancers17091436","article-title":"Clinical utility of optical genome mapping as an additional tool in a standard cytogenetic workup in hematological malignancies","volume":"17","author":"Toruner","year":"2025","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jmoldx.2026.01.002_bib18","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1002\/ajh.27688","article-title":"Integration of optical genome mapping in the cytogenomic and molecular work-up of hematological malignancies: expert recommendations from the international consortium for optical genome mapping","volume":"100","author":"Kanagal-Shamanna","year":"2025","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jmoldx.2026.01.002_bib19","series-title":"ISCN 2020: An International System for Human Cytogenomic Nomenclature (2020)","author":"McGowan-Jordan","year":"2020"},{"key":"10.1016\/j.jmoldx.2026.01.002_bib20","series-title":"ISCN 2024: An International System for Human Cytogenomic Nomenclature (2024)","author":"Hastings","year":"2020"},{"key":"10.1016\/j.jmoldx.2026.01.002_bib21","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1002\/ajh.27175","article-title":"A framework for the clinical implementation of optical genome mapping in hematologic malignancies","volume":"99","author":"Levy","year":"2024","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jmoldx.2026.01.002_bib22","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jmoldx.2016.10.002","article-title":"Standards and guidelines for the interpretation and reporting of sequence variants in cancer: a joint consensus recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists","volume":"19","author":"Li","year":"2017","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.jmoldx.2026.01.002_bib23","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1038\/s41436-019-0545-7","volume":"21","author":"Mikhail","year":"2019","journal-title":"Genet Med"}],"container-title":["The Journal of Molecular Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525157826000061?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525157826000061?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T10:40:26Z","timestamp":1774435226000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525157826000061"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S1525157826000061"],"URL":"https:\/\/doi.org\/10.1016\/j.jmoldx.2026.01.002","relation":{},"ISSN":["1525-1578"],"issn-type":[{"value":"1525-1578","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Technical Validation and Prospective Clinical Utility of Optical Genome Mapping in Acute Leukemia Workup","name":"articletitle","label":"Article Title"},{"value":"The Journal of Molecular Diagnostics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmoldx.2026.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2026 Published by Elsevier Inc. on behalf of the Association for Molecular Pathology and American Society for Investigative Pathology. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}